ISSN 2412-4036 (print)
ISSN 2713-1823 (online)

Thrombotic microangiopathy in a young patient with malignant arterial hypertension: The possible role of chronic heat stress (A clinical observation)

K.A Demyanova, N.L. Kozlovskaya, M.V. Khachatryan, A.S.E. Ojama Nchama, T.V. Bondarenko, Zh.D. Kobalava

1) RUDN University, Moscow, Russian Federation; 2) A.K. Eramischantsev City Clinical Hospital of the Department of Healthcare of Moscow, Moscow, Russian Federation
Abstract. Thrombotic microangiopathy (TMA) is one of the manifestations of malignant arterial hypertension (MAH), requiring differential diagnosis from primary forms of the disease. This article describes a clinical case of TMA associated with MAH in a 38-year-old patient with prolonged exposure to high temperatures. The disease manifested with an increase in blood pressure (BP) to 212/120 mmHg and acute visual impairment. The patient had severe azotemia (creatinine level up to 350 μmol/L), proteinuria up to 1.75 g/day, and stage 3 hypertensive retinopathy. A kidney biopsy revealed signs of acute and chronic TMA, while complement-mediated forms of the disease were excluded. Combination antihypertensive therapy and heat stress management resulted in stabilization of blood pressure and renal function (creatinine 218–228 μmol/L, eGFR ≈ 31 mL/min/1.73 m²). Current observation demonstrates that TMA in young patients can remain to be asymptomatic for a long time. If TMA is detected, a thorough differential diagnosis is necessary. Renin-angiotensin-aldosterone system (RAAS) blockers may be prescribed even in cases of reduced eGFR, in case of its monitoring. Chronic heat stress can be considered to be a potential trigger for the disease.

Keywords

thrombotic microangiopathy
malignant hypertension
chronic heat stress
acute kidney injury

References

1. Lane DA, Lip GY, Beevers DG. Improving survival of malignant hypertension patients over 40 years. Am J Hypertens. 2009;22(11):1199–204.

PMID: 19696746. https://doi.org/10.1038/ajh.2009.153

2. Shantsila A, Lip GYH. Malignant hypertension revisited – does this still exist? Am J Hypertens. 2017;30(6):543–49.

PMID: 28200072. https://doi.org/10.1093/ajh/hpx008

3. van den Born BJ, Honnebier UP, Koopmans RP, van Montfrans GA. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension. 2005;45(2):246–51.

PMID: 15596574. https://doi.org/10.1161/01.HYP.0000151620.17905.ee

4. Fakhouri F, Schwotzer N, Fremeaux-Bacchi V. How I diagnose and treat atypical hemolytic uremic syndrome. Blood. 2023;141(9):985–95.

PMID: 36322940. https://doi.org/10.1182/blood.2022017860

5. Johnson RJ, Sanchez-Lozada LG, Newman LS, Lanaspa MA, Diaz HF, Lemery J et al. Climate change and the kidney. Ann Nutr Metab. 2019;74 Suppl 3:38–44.

PMID: 31203298. https://doi.org/10.1159/000500344

6. Vivarelli M, Barratt J, Beck LH Jr, Fakhouri F, Gale DP, Goicoechea de Jorge E et al.; for Conference Participants. The role of complement in kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2024;106(3):369–91.

PMID: 38844295. https://doi.org/10.1016/j.kint.2024.05.015

7. Козловская Н.Л., Коротчаева Ю.В., Акаева М.И., Моисеев С.В. Злокачественная артериальная гипертония с тромботической микроангиопатией: причина или следствие? Клиническая фармакология и терапия. 2025;34(2):74–83. (Kozlovskaya NL, Korotchaeva YuV, Akaeva MI, Moiseev SV. Malignant arterial hypertension with thrombotic microangiopathy: Cause or consequence? Klinicheskaya farmakologiya i terapiya = Clinical Pharmacology and Therapy. 2025;34(2):74–83 (In Russ.)).

EDN: VARTJU. https://doi.org/10.32756/0869-5490-2025-2-74-83

8. Cavero T, Arjona E, Soto K, Caravaca-Fontan F, Rabasco C, Bravo L et al.; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome. Kidney Int. 201;96(4):995–1004.

PMID: 31420192. https://doi.org/10.1016/j.kint.2019.05.014

9. Glaser J, Lemery J, Rajagopalan B, Diaz HF, Garcia-Trabanino R, Taduri G et al. Climate change and the emergent epidemic of CKD from heat stress in rural communities: The case for heat stress nephropathy. Clin J Am Soc Nephrol. 2016;11(8):1472–83.

PMID: 27151892. https://doi.org/10.2215/CJN.13841215

10. Roncal-Jimenez C, Garcia-Trabanino R, Barregard L, Lanaspa MA, Wesseling C, Harra T et al. Heat stress nephropathy from exercise-induced uric acid crystalluria: A perspective on mesoamerican nephropathy. Am J Kidney Dis. 2016;67(1):20–30.

PMID: 26455995. https://doi.org/10.1053/j.ajkd.2015.08.021

11. Endo K, Hayashi K, Hara Y, Miyake A, Takano K, Horikawa T et al. Impact of early initiation of renin–angiotensin blockade on renal outcomes. BMC Nephrol. 2023;24(1):68.

PMID: 36949416. PMCID: PMC10035153. https://doi.org/10.1186/s12882-023-03117-1

12. Boulestreau R, Lorthioir A, Dreau H, Persu A, Cremer A, Tharaux PL et al.; for the HAMA investigators. Baseline characteristics of patients with malignant hypertension. J Hypertens. 2024;42(12):2131–38.

PMID: 39351849. https://doi.org/10.1097/HJH.0000000000003851

About the Authors

Ksenia A. Demyanova, MD, PhD (Medicine), associate professor of the Department of internal medicine with a course in cardiology and functional diagnostics named after V.S. Moiseyev, RUDN University; nephrologist at the Center for assistance to pregnants with kidney pathology, A.K. Eramischantsev City Clinical Hospital , Moscow, Russian Federation
E-mail: ksedem@gmail.com
ORCID: https://orcid.org/0000-0001-8927-5841
Natalya L. Kozlovskaya, MD, Dr. Sci. (Medicine), professor, professor of the Department of internal medicine with a course in cardiology and functional diagnostics named after V.S. Moiseyev, RUDN University; head of the Center for assistance to pregnants with kidney pathology, A.K. Eramischantsev City Clinical Hospital, Moscow, Russian Federation.
E-mail: nkozlovskaya@yandex.ru
ORCID: https://orcid.org/0000-0002-4275-0315
Milena V. Khachatryan, clinical resident of the Department of internal medicine with a course in cardiology and functional diagnostics named after V.S. Moiseyev, RUDN University, Moscow, Russian Federation.
E-mail: kha4atryan.milena@yandex.ru
ORCID: https://orcid.org/0009-0009-0915-7438
Alexia S.E. Ojama Nchama, MD, postgraduate student of the Department of internal medicine with a course in cardiology and functional diagnostics named after V.S. Moiseev, RUDN University, Moscow, Russian Federation.
E-mail: Alex.sinfo@mail.ru
ORCID: https://orcid.org/0009-0006-8367-2639
Tatyana V. Bondarenko, MD, head of the Interdistrict Center of Nephrology, head of the Department of nephrology, nephrologist at A.K. Eramischantsev City Clinical Hospital, Moscow. Russian Federation
E-mail: tatiana.v.bondarenko@mail.ru
ORCID: https://orcid.org/0000-0003-0701-1805
Zhanna D. Kobalava, MD, Dr. Sci. (Medicine), professor, corresponding member of RAS, head of the Department of internal medicine with a course in cardiology and functional diagnostics named after academician V.S. Moiseev, RUDN University, E-mail: zkobalava@mail.ru
ORCID: https://orcid.org/0000-0002-5873-1768

Similar Articles